A Study to Evaluate the Allergenicity and Safety of Recombinant Human C1 Inhibitor (rhC1INH) in Patients With Rabbit Allergy (RA) and/or Cow's Milk Allergy (CMA)

Trial Profile

A Study to Evaluate the Allergenicity and Safety of Recombinant Human C1 Inhibitor (rhC1INH) in Patients With Rabbit Allergy (RA) and/or Cow's Milk Allergy (CMA)

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Jun 2016

At a glance

  • Drugs Conestat alfa (Primary) ; Conestat alfa (Primary)
  • Indications Milk hypersensitivity
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Jun 2016 New trial record
    • 13 May 2016 Results published in the Journal of Allergy and Clinical Immunology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top